{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:29:01Z","timestamp":1762874941575},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.amjcard.2005.06.027","type":"journal-article","created":{"date-parts":[[2005,7,19]],"date-time":"2005-07-19T10:20:40Z","timestamp":1121768440000},"page":"54-60","source":"Crossref","is-referenced-by-count":59,"special_numbering":"S","title":["Early Time to Benefit with Intensive Statin Treatment: Could It Be the Pleiotropic Effects?"],"prefix":"10.1016","volume":"96","author":[{"given":"Kausik K.","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.amjcard.2005.06.027_bib1","doi-asserted-by":"crossref","first-page":"I11","DOI":"10.1002\/clc.4960261305","article-title":"Effects of statins in reducing thrombotic risk and modulating plaque vulnerability","volume":"26","author":"Libby","year":"2003","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2005.06.027_bib2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00041433-200412000-00003","article-title":"Intensive statin therapy in acute coronary syndromes","volume":"15","author":"Ray","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.amjcard.2005.06.027_bib3","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.027_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/01.ATV.21.1.115","article-title":"Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering","volume":"21","author":"Sparrow","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2005.06.027_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/01.ATV.0000044458.23905.3B","article-title":"Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage","volume":"23","author":"Sironi","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2005.06.027_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2125.2002.01677.x","article-title":"Direct in vivo evidence of a vascular statin","volume":"54","author":"Omori","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2005.06.027_bib7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0024-3205(00)00680-9","article-title":"Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect","volume":"67","author":"Inoue","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.amjcard.2005.06.027_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11239-004-0205-9","article-title":"Pathological changes in acute coronary syndromes","volume":"18","author":"Ray","year":"2004","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.amjcard.2005.06.027_bib9","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.06.027_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.06.027_bib11","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2005.06.027_bib12","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2005.06.027_bib13","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/01.CIR.0000091404.09558.AF","article-title":"High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study","volume":"108","author":"Kinlay","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.027_bib14","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/01.CIR.0000068312.21969.C8","article-title":"Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia","volume":"107","author":"Ballantyne","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.027_bib15","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.amjcard.2003.08.048","article-title":"Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive protein","volume":"92","author":"Sager","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.06.027_bib16","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJM199010043231404","article-title":"Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia","volume":"323","author":"Buchwald","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.06.027_bib17","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.06.027_bib18","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.06.027_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.hpc.0000154979.98731.5d","article-title":"Time to benefit","volume":"4","author":"Ray","year":"2005","journal-title":"Crit Pathways Cardiol"},{"key":"10.1016\/j.amjcard.2005.06.027_bib20","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.CIR.97.15.1440","article-title":"Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)","volume":"97","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.027_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","article-title":"Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease","volume":"352","author":"Nissen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.06.027_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJMoa012295","article-title":"Widespread coronary inflammation in unstable angina","volume":"347","author":"Buffon","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.06.027_bib23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/01.CIR.0000025609.13806.31","article-title":"Multiple atherosclerotic plaque rupture in acute coronary syndrome","volume":"106","author":"Rioufol","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.027_bib24","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nm1102-1257","article-title":"Stabilization of atherosclerotic plaques","volume":"8","author":"Libby","year":"2002","journal-title":"Nat Med"},{"issue":"suppl 4A","key":"10.1016\/j.amjcard.2005.06.027_bib25","doi-asserted-by":"crossref","first-page":"4B","DOI":"10.1016\/S0002-9149(02)03267-8","article-title":"Mechanisms of plaque stabilization with statins","volume":"91","author":"Libby","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.06.027_bib26","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","article-title":"From vulnerable plaque to vulnerable patient","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.027_bib27","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/01.CIR.0000087481.55887.C9","article-title":"From vulnerable plaque to vulnerable patient","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.027_bib28","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0002-9149(01)02095-1","article-title":"Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men","volume":"88","author":"Laufs","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.06.027_bib29","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.ATV.0000060461.64771.F0","article-title":"Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the Rho family","volume":"23","author":"Masamura","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2005.06.027_bib30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/01.ATV.0000065194.00822.C7","article-title":"Integral role of RhoA activation in monocyte adhesion-triggered tissue factor expression in endothelial cells","volume":"23","author":"Ishibashi","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2005.06.027_bib31","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1161\/01.ATV.0000102551.91154.96","article-title":"Gene expression in macrophage-rich inflammatory cell infiltrates in human atherosclerotic lesions as studied by laser microdissection and DNA array","volume":"23","author":"Tuomisto","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914905010854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914905010854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T07:21:48Z","timestamp":1548314508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914905010854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0002914905010854"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2005.06.027","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}